Top compounds associated with response to LARS2


Feature Type Standardized
Nominal ANOVA
mRNA Doxorubicin gCSI pan-cancer AAC 0.14 0.005
mRNA FK866 CTRPv2 pan-cancer AAC 0.11 0.005
mRNA Bleomycin GDSC1000 pan-cancer AAC 0.11 0.005
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.005
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.006
mRNA staurosporine CTRPv2 pan-cancer AAC -0.21 0.006
mRNA BMS-345541 CTRPv2 pan-cancer AAC 0.1 0.006
mRNA parbendazole CTRPv2 pan-cancer AAC 0.089 0.006
mRNA Bax channel blocker CTRPv2 pan-cancer AAC 0.11 0.007
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.099 0.007
Download CSV